MedCity News

AUGUST 12, 2024

FDA approval of Ascendis Pharma’s Yorvipath is just in time for patients with hypoparathyroidism as Takeda Pharmaceutical will soon stop making the only drug therapy for the rare disorder. But competition could come from others, including an AstraZeneca peptide in late-stage development.

FDA 301

FDA Pharma Competition Pharmaceutical 301

European Pharmaceutical Review

APRIL 19, 2024

Conclusions from the meeting of the special European Council (17-18 April 2024) have recognised a need for new European competitiveness deal “anchored in a fully integrated Single Market”. The post Enhancing competitiveness of European life sciences appeared first on European Pharmaceutical Review.

Competition 105

Competition Pharmaceutical Manufacturing Specialization 105

MedCity News

AUGUST 3, 2022

Alnylam Pharmaceuticals drug Onpattro, an FDA-approved treatment for nerve pain caused by hereditary transthyretin amyloidosis, now has Phase 3 data showing it can also help the much larger group of patients suffering heart problems from the rare protein disease.

FDA 272

FDA Competition Pharmaceutical Patients 272

MedCity News

MARCH 20, 2023

Takeda Pharmaceutical drug TAK-279 achieved the main goal of a mid-stage clinical trial in plaque psoriasis, setting the stage for Phase 3.

Competition 246

Competition Pharmaceutical Biopharma Pharma 246

pharmaphorum

DECEMBER 14, 2022

For years, Jazz Pharmaceuticals has dominated the market in treating narcolepsy with cataplexy. But increased competition is on the horizon. Avadel Pharmaceuticals developed Lumryz, a sodium oxybate that is a once-daily, extended-release oral suspension that gained tentative FDA approval in July 2022. Classic treatment options.

Competition 114

Competition FDA Pharmaceutical Marketing 114

Healthcare Success

JUNE 6, 2022

What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. . For these reasons and more, it’s imperative to identify your unique selling propositions, review them, and revise them regularly to remain competitive. . So, how can your brand stay competitive? The answer is twofold.

Competition 109

Competition Healthcare Healthcare Marketing 109

Fierce Pharma

JUNE 23, 2023

After years of using the patent system to delay competition from a rival company and then exhausting that ploy early this year, Jazz Pharmaceuticals is taking a new route—suing the FDA.

FDA 218

FDA Competition Pharmaceutical 218

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. What are the biggest challenges in marketing pharmaceuticals?

Marketing 52

Marketing Pharmaceutical Pharma Education 52

European Pharmaceutical Review

SEPTEMBER 4, 2023

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

Competition 98

Competition Biopharma Pharmaceutical Government 98

PM360

JANUARY 24, 2025

AI drives automation and optimization that empower pharmaceutical marketers to rapidly scale commercialization-oriented content and activities. The transformative impact of AI on pharmaceutical marketing is significant, with much to consider regarding its promise and how its reshaping the industry.

Marketing 64

Marketing Pharmaceutical Pharma Sales pitches 64

European Pharmaceutical Review

OCTOBER 27, 2023

According to The Biosimilar Medicines Group, part of Medicines for Europe, a new report by IQVIA indicates there is a window of opportunity for the EU to foster future-proof biosimilar competition. This publication has come in wake of the EU actively reviewing its Pharmaceutical Legislation.

Competition 105

Competition Medicine Marketing Pharmaceutical 105

European Pharmaceutical Review

FEBRUARY 17, 2025

For the pharmaceutical industry, where rapid innovation requires continuous upskilling and reskilling of employees, this reform could significantly improve access to tailored training opportunities.

Training 59

Training Pharmaceutical Government Manufacturing 59

Pharma Marketing Network

JANUARY 11, 2025

With competition intensifying and regulations becoming stricter, crafting impactful campaigns requires both creativity and precision. Think of pharmaceutical advertising as a delicate balancing actits about connecting with your audience while staying compliant. How can you ensure your strategy stands out?

Pharmaceutical 52

Pharmaceutical Marketing Pharma Healthcare Provider 52

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally.

Competition 104

Competition Biopharma Government Manufacturing 104

Pharma Marketing Network

MARCH 31, 2025

Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. This article explores the top trends, technologies, and targeting strategies shaping the future of pharmaceutical marketing.

Marketing 52

Marketing Pharmaceutical Pharma Media 52

European Pharmaceutical Review

NOVEMBER 25, 2022

Should LY03010 receive US Food and Drug Administration (FDA) approval, Luye Pharma will need to provide solid marketing and competitive pricing to set it apart from competitors and convince payers to reimburse it.”. The post Promising schizophrenia drug faces tough competition appeared first on European Pharmaceutical Review.

Competition 105

Competition Food and Drug Administration Pharma Food 105

MedCity News

OCTOBER 1, 2024

The most advanced program has results from a Phase 2 test in China suggesting it could be competitive with other medications that target the GLP-1 and GIP receptors to trigger weight loss. Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui.

Competition 291

Competition Medical Pharmaceutical Biopharma 291

Infuse Medical

SEPTEMBER 3, 2024

In today’s rapidly evolving digital landscape, pharmaceutical sales teams face unparalleled challenges. Enter Showpad-a leading sales enablement platform designed to revolutionize how pharmaceutical sales teams operate. Learn more about cutting-edge technology that is reshaping the future of pharmaceutical sales.

Pharmaceutical Sales 130

Pharmaceutical Sales Sales Pharmaceutical Sales presentations 130

Pharma Marketing Network

FEBRUARY 17, 2025

Introduction: Choosing the right pharmaceutical marketing company is like picking a strategic partnerit can make or break your brands success. In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever.

Marketing 52

Marketing Pharmaceutical Pharma Prescription 52

Fierce Pharma

MARCH 29, 2024

A little more than a year after Hikma Pharmaceuticals accused Amarin of “deliberately and meticulously” hamstringing supplies of the main ingredient in its only marketed drug, Vascepa, to thwart po | A little more than a year after Hikma Pharmaceuticals accused Amarin of “deliberately and meticulously” hamstringing supplies of the main ingredient in (..)

Competition 190

Competition Pharmaceutical Marketing 190

MedCity News

MAY 29, 2024

The therapy could pose competition to Eylea, the blockbuster Regeneron Pharmaceuticals eye drug. Merck’s EyeBio acquisition brings a lead program ready for pivotal testing in diabetic macular edema. The post Merck Sees Pipeline Diversification Opportunity in $1.3B EyeBio Acquisition appeared first on MedCity News.

Competition 167

Competition Leads Pharmaceutical Biopharma 167

European Pharmaceutical Review

APRIL 28, 2023

The European Commission ’s (EC’s) reform of the EU pharmaceutical legislation published on 26 April 2023, adopted a proposal for a new Directive and a new Regulation. These amend and replace the existing general pharmaceutical legislation.

Pharmaceutical 98

Pharmaceutical Pharma Medicine Competition 98

European Pharmaceutical Review

SEPTEMBER 28, 2023

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 105

European Pharmaceutical Review

JUNE 24, 2022

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

European Pharmaceutical Review

JULY 15, 2022

The pharmaceutical sector is not typically seen as a highly polluting, ‘heavy industry’ but it is far from green. A deep carbon footprint is a common hallmark of energy intensive manufacturing processes – and the manufacture of pharmaceuticals is no exception. There is also a reputational imperative to act on carbon emissions.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Government 105

Pharmaceutical Technology

JULY 17, 2024

In January, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act.

Pharmaceutical 98

Pharmaceutical Competition Marketing 98

European Pharmaceutical Review

DECEMBER 4, 2023

The (bio)pharmaceutical industry is currently facing numerous hurdles in its path to high-efficiency production that are more complex and pressing than ever before. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production. Enter the era of benchtop NMR solutions.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 105

World of DTC Marketing

JUNE 7, 2021

The US Federal Trade Commission is taking a more aggressive antitrust approach as eight US antitrust bills targeting the pharmaceutical industry have been recently introduced. Eight US antitrust bills targeting the pharmaceutical industry have been recently introduced, addressing a gamut of alleged anti-competitive activity.

Pharma 187

Pharma Retail Competition Prescription 187

Pharma Marketing Network

JULY 12, 2023

The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. One way is to use patient-generated content (PGC).

Pharmaceutical 98

Pharmaceutical Marketing Patients Healthcare Provider 98

MaBiCo

FEBRUARY 20, 2023

The Benefits of a Sales Pilot for Pharmaceutical Products A sales pilot is a short-term experiment that tests a product’s sales performance or a new sales approach. To say it in a few words, a sales pilot is a test to assess whether a pharmaceutical company should invest or not in the promotion of a product.

Pharmaceutical products 98

Pharmaceutical products Sales Pharmaceutical Marketing 98

European Pharmaceutical Review

FEBRUARY 13, 2025

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

Medicine 59

Medicine Pharmaceutical manufacturing Manufacturing Competition 59

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. appeared first on European Pharmaceutical Review.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

Pharma Marketing Network

MARCH 20, 2025

With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Second, competition among pharmaceutical brands is growing. How does AI impact pharma marketing?

Healthcare 59

Healthcare Healthcare Pharma Marketing 59

World of DTC Marketing

OCTOBER 5, 2021

drug pricing system is filled with confusing numbers , and many entities profit off the flow of drugs, but pharmaceutical companies retain a vast majority of the proceeds” Big pharma IS big business. For 17 of the 20 top-selling drugs worldwide in 2020, pharmaceutical corporations made more money from U.S.

Pharma 241

Pharma Insurance Sales Government 241

Axxelus

NOVEMBER 10, 2021

A contract sales organization (CSO) can be an enormous boon to a pharmaceutical or medical device company’s operations. Being able to quickly fill sales rep positions with skilled and motivated individuals is a vital competitive advantage in a crowded, but lucrative, field.

Sales 130

Sales Competition Medical Pharmaceutical 130

Pharma Marketing Network

MARCH 18, 2025

The pharmaceutical industry is competitive, fast-paced, and highly regulated, making it essential for marketers to stay ahead of trends, build strong industry relationships, and continuously improve their strategic thinking. Introduction Climbing the ladder in marketing pharma requires more than just technical skills.

Marketing 52

Marketing Pharma Networking Media 52

European Pharmaceutical Review

MARCH 8, 2024

Researchers have described the impact of data integrity, GAMP 5 and quality by design (QbD) principles on pharmaceutical quality assurance (QA) , highlighting the importance of data integrity through various case studies. GAMP 5 update: computerized system expectations for pharma manufacturers Benefits of Pharma 4.0

Pharmaceutical 98

Pharmaceutical Pharma Safety Manufacturing 98